Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 71-80 of 163 (Search time: 0.005 seconds).

  Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis (Journal article)

  Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study (Journal article)

  Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions (Journal article)

  Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration (Journal article)

  Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study (Journal article)

  Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer (Journal article)

  The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property (Journal article)

  Switching benchmarks in cancer of unknown primary: from autopsy to microarray (Journal article)

  p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study (Journal article)

  Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit (Journal article)